We are live on ! Find out more
AI

ArchPoint Investors Portfolio holdings

AUM $420M
1-Year Est. Return 42.19%
This Fund
S&P 500
This Quarter Est. Return
+0.05%
1 Year Est. Return
+42.19%
3 Year Est. Return
+98.24%
5 Year Est. Return
+100.5%
10 Year Est. Return
+371.01%
AUM
$211M
AUM Growth
-$33.6M
Cap. Flow
-$28.2M
Cap. Flow %
-13.35%
Top 10 Hldgs %
69.11%
Holding
65
New
7
Increased
7
Reduced
12
Closed
9

Top Buys

Rank Stock Value
1
CFLT
Confluent
CFLT
+$1.51M
2
MMD
MainStay MacKay DefinedTerm Municipal Opportunities Fund
MMD
+$710K
3
MO icon
Altria Group
MO
+$587K
4
AMPL icon
Amplitude
AMPL
+$268K
5
MRK icon
Merck
MRK
+$206K

Top Sells

Rank Stock Value
1
GBT
Global Blood Therapeutics, Inc.
GBT
+$11.5M
2
ABCL icon
AbCellera Biologics
ABCL
+$5.8M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$3.47M
4
AMZN icon
Amazon
AMZN
+$3.35M
5
META icon
Meta Platforms (Facebook)
META
+$2.67M

Sector Composition

Rank Sector Weight
1 Communication Services 28%
2 Consumer Discretionary 17.49%
3 Energy 16.44%
4 Healthcare 12.22%
5 Technology 6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GOOGL icon
1
Alphabet (Google) Class A
GOOGL
$4.36T
$57.4M 27.17%
650,500
-36,560
-5% -$3.47M
DMLP icon
2
Dorchester Minerals
DMLP
$1.33B
$16.3M 7.73%
545,759
– –
AMZN icon
3
Amazon
AMZN
$2.92T
$14.9M 7.07%
177,755
-33,885
-16% -$3.35M
LZB icon
4
La-Z-Boy
LZB
$1.58B
$10.7M 5.04%
466,746
– –
GPC icon
5
Genuine Parts
GPC
$17.1B
$9.06M 4.29%
51,933
+493
+1% +$85.8K
RXRX icon
6
Recursion Pharmaceuticals
RXRX
$1.59B
$8.59M 4.07%
1,114,626
-1,500
-0.1% -$14.7K
TMO icon
7
Thermo Fisher Scientific
TMO
$213B
$8.09M 3.83%
14,680
– –
IEFA icon
8
iShares Core MSCI EAFE ETF
IEFA
$190B
$7.26M 3.44%
117,752
– –
ATVI
9
DELISTED
Activision Blizzard
ATVI
$6.99M 3.31%
91,260
– –
CW icon
10
Curtiss-Wright
CW
$26.7B
$6.7M 3.17%
40,120
– –
RGNX icon
11
Regenxbio
RGNX
$620M
$5.09M 2.41%
224,278
-28,350
-11% -$641K
EPD icon
12
Enterprise Products Partners
EPD
$82.3B
$4.07M 1.93%
168,823
+3,967
+2% +$97.7K
VTIP icon
13
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
$19.1B
$3.87M 1.83%
82,943
– –
XOP icon
14
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$3.65B
$3.73M 1.77%
27,487
-613
-2% -$88.9K
LNG icon
15
Cheniere Energy
LNG
$55.2B
$3.56M 1.68%
23,725
– –
CVX icon
16
Chevron
CVX
$392B
$3.52M 1.67%
19,610
– –
MMP
17
DELISTED
Magellan Midstream Partners, L.P.
MMP
$2.75M 1.3%
54,849
– –
NAUT icon
18
Nautilus Biotechnolgy
NAUT
$124M
$2.61M 1.24%
1,449,551
– –
EMLP icon
19
First Trust North American Energy Infrastructure Fund
EMLP
$4.11B
$2.14M 1.01%
80,000
– –
MTTR
20
DELISTED
Matterport, Inc. Class A Common Stock
MTTR
$2.08M 0.98%
741,854
+56,720
+8% +$181K
ET icon
21
Energy Transfer Partners
ET
$70.1B
$2.05M 0.97%
172,570
– –
PSLV icon
22
Sprott Physical Silver Trust
PSLV
$12B
$2.04M 0.96%
247,214
– –
MPLX icon
23
MPLX
MPLX
$59.3B
$1.95M 0.93%
59,504
– –
AMLP icon
24
Alerian MLP ETF
AMLP
$13B
$1.81M 0.86%
47,675
-18,500
-28% -$727K
BABA icon
25
Alibaba
BABA
$293B
$1.81M 0.86%
20,590
– –
1
2 3

Similar funds

HWMG
Hurlow Wealth Management Group Bloomington, Indiana $420M AUM 16.85% 1-Year Est. Return
MG
MilWealth Group Milwaukee, Wisconsin $420M AUM 12.37% 1-Year Est. Return
IMA
Investment Management Associates Greenwood Village, Colorado $420M AUM 11.81% 1-Year Est. Return
CMHI
CVC Management Holdings II St. Helier, Jersey $420M AUM 0.05% 1-Year Est. Return
TFP
Triune Financial Partners Overland Park, Kansas $421M AUM 22.09% 1-Year Est. Return
BRM
Boston Research & Management Manchester, Massachusetts $421M AUM 16.18% 1-Year Est. Return
CWAF
Core Wealth Advisors (Florida) Lakeland, Florida $419M AUM 16.86% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return

ArchPoint Investors's Q4 2022 Portfolio in Review

As of Q4 2022, ArchPoint Investors held 65 positions worth $211M, down 14% from $245M the previous quarter. Its ten largest holdings account for 69% of the portfolio.

ArchPoint Investors withdrew a net $28.2M in Q4 2022, closing 9 positions and reducing 12 holdings. Its most notable exit was Global Blood Therapeutics, Inc., an estimated $11.5M position sold in full.

By sector, the portfolio is most concentrated in Communication Services at 28% of assets, down from 29% a quarter earlier, followed by Consumer Discretionary and Energy.

Against the trend, ArchPoint Investors opened a new position in Confluent worth $1.45M.

  • ArchPoint Investors's largest Q4 2022 buy was Confluent: 65,184 shares worth $1.45M.
  • ArchPoint Investors added most to Altria Group in Q4 2022, an estimated $587K increase.
  • ArchPoint Investors's biggest Q4 2022 reduction was AbCellera Biologics, cutting an estimated $5.8M.
  • ArchPoint Investors fully exited Global Blood Therapeutics, Inc. in Q4 2022, selling an estimated $11.5M.
  • ArchPoint Investors's ten largest holdings make up 69% of its $211M portfolio in Q4 2022.
  • ArchPoint Investors opened 7 new positions and closed 9 in Q4 2022.
  • ArchPoint Investors's portfolio value fell 14% quarter-over-quarter to $211M.

Based on ArchPoint Investors's 13F filing for Q4 2022, filed 13 Feb 2023.